BRPI0911650A2 - peptídeos imitando fator de crescimento e seus usos - Google Patents

peptídeos imitando fator de crescimento e seus usos

Info

Publication number
BRPI0911650A2
BRPI0911650A2 BRPI0911650A BRPI0911650A BRPI0911650A2 BR PI0911650 A2 BRPI0911650 A2 BR PI0911650A2 BR PI0911650 A BRPI0911650 A BR PI0911650A BR PI0911650 A BRPI0911650 A BR PI0911650A BR PI0911650 A2 BRPI0911650 A2 BR PI0911650A2
Authority
BR
Brazil
Prior art keywords
growth factor
mimicking peptides
factor mimicking
peptides
growth
Prior art date
Application number
BRPI0911650A
Other languages
English (en)
Inventor
Eun Mi Kim
Jun Young Choi
Yong-Ji Chung
Young Deug Kim
Original Assignee
Caregen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caregen Co Ltd filed Critical Caregen Co Ltd
Priority to BR122020010541-0A priority Critical patent/BR122020010541B1/pt
Priority to BR122020010515-1A priority patent/BR122020010515B1/pt
Publication of BRPI0911650A2 publication Critical patent/BRPI0911650A2/pt
Publication of BRPI0911650B1 publication Critical patent/BRPI0911650B1/pt
Publication of BRPI0911650B8 publication Critical patent/BRPI0911650B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
BRPI0911650A 2008-04-11 2009-03-06 peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento BRPI0911650B8 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR122020010541-0A BR122020010541B1 (pt) 2008-04-11 2009-03-06 Peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento
BR122020010515-1A BR122020010515B1 (pt) 2008-04-11 2009-03-06 Peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2008-0033687 2008-04-11
KR1020080033687A KR101021197B1 (ko) 2008-04-11 2008-04-11 성장인자―미미킹 펩타이드 및 그의 용도
PCT/KR2009/001134 WO2009125925A2 (ko) 2008-04-11 2009-03-06 성장인자―미미킹 펩타이드 및 그의 용도

Publications (3)

Publication Number Publication Date
BRPI0911650A2 true BRPI0911650A2 (pt) 2016-07-12
BRPI0911650B1 BRPI0911650B1 (pt) 2021-04-27
BRPI0911650B8 BRPI0911650B8 (pt) 2021-05-25

Family

ID=41162356

Family Applications (3)

Application Number Title Priority Date Filing Date
BRPI0911650A BRPI0911650B8 (pt) 2008-04-11 2009-03-06 peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento
BR122020010515-1A BR122020010515B1 (pt) 2008-04-11 2009-03-06 Peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento
BR122020010541-0A BR122020010541B1 (pt) 2008-04-11 2009-03-06 Peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento

Family Applications After (2)

Application Number Title Priority Date Filing Date
BR122020010515-1A BR122020010515B1 (pt) 2008-04-11 2009-03-06 Peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento
BR122020010541-0A BR122020010541B1 (pt) 2008-04-11 2009-03-06 Peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento

Country Status (8)

Country Link
US (1) US8501689B2 (pt)
EP (1) EP2275440B1 (pt)
JP (1) JP5361988B2 (pt)
KR (1) KR101021197B1 (pt)
CN (1) CN102027008B (pt)
BR (3) BRPI0911650B8 (pt)
ES (1) ES2616658T3 (pt)
WO (1) WO2009125925A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101198918B1 (ko) * 2009-09-01 2012-11-07 (주)케어젠 Ｗｎｔ１０?유래 펩타이드 및 그의 용도
KR101949270B1 (ko) * 2010-11-30 2019-02-19 (주)아모레퍼시픽 펩타이드 또는 단백질 안정화제
KR101155151B1 (ko) * 2011-06-21 2012-06-11 (주)케어젠 성장인자?유래 펩타이드 및 이의 용도
KR101155152B1 (ko) * 2011-06-21 2012-06-11 (주)케어젠 성장인자?유래 펩타이드 및 이의 용도
CN103923210A (zh) * 2013-01-14 2014-07-16 山东新时代药业有限公司 一种胸腺法新的固相合成工艺
KR20150130614A (ko) * 2014-05-13 2015-11-24 (주)케어젠 성장인자 활성을 나타내는 펩타이드 및 그의 용도
KR101831887B1 (ko) * 2016-03-09 2018-02-27 (주)케어젠 발모 촉진 활성 및 멜라닌 생성 촉진 활성을 나타내는 펩타이드 및 이의 용도
AU2016397332B2 (en) 2016-03-18 2020-04-30 Caregen Co., Ltd. Conjugate of finasteride with peptide
KR101948238B1 (ko) 2016-08-19 2019-02-14 (주)케어젠 미녹시딜과 펩타이드의 결합체
KR102016658B1 (ko) * 2017-02-16 2019-08-30 (주)케어젠 살리실산과 펩타이드의 결합체
EA201991699A1 (ru) * 2017-02-16 2020-01-21 Кареджен Ко., Лтд. Конъюгат салициловой кислоты и пептида
KR102160566B1 (ko) 2019-01-16 2020-09-28 (주)케어젠 미녹시딜과 펩타이드의 결합체
KR102221365B1 (ko) 2019-05-07 2021-03-02 (주)케어젠 트롤록스-펩타이드 결합체 및 그의 용도
KR102658336B1 (ko) * 2020-06-08 2024-04-17 김재환 리젠타이드-034 및 이를 포함하는 피부 상태 개선용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034997A (ja) * 1983-05-09 1985-02-22 ジヨージ、ジヨセフ、トダロ 生物学的活性ポリペプチド類
US4444760A (en) 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor
AU5249786A (en) * 1985-01-29 1986-08-07 Oncogen Wound healing compositions
US5436228A (en) * 1990-12-12 1995-07-25 Postlethwaite; Arnold E. Chemotactic wound healing peptides
AU4238493A (en) 1992-05-08 1993-12-13 Thomas Jefferson University IGF-1 analogs
BR9407035A (pt) * 1993-06-29 1996-03-12 Chiron Corp Fragmento de fator de crescimento de queratinócitos conjugado composição terapêutica molécula de DNA vetor de expressão célula hospedeira processo para produzir fragmento de fator de crescimento de queratinócitos processo para cicatrização de ferimento e processo de tratamento de doença hiperproliferativa da epiderme
ES2293137T3 (es) * 1995-10-11 2008-03-16 Novartis Vaccines And Diagnostics, Inc. Combinacion de pdgf, kgf,igf e igfbp para curacion de heridas.
CN1232532C (zh) * 1996-12-27 2005-12-21 暨南大学生物工程研究所 成纤维细胞生长因子－2结构类似物,其生产方法及应用
EP0877031A1 (en) * 1997-05-06 1998-11-11 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) TGF-Beta1 derived peptides mimicking the activity of transforming growth factor-Beta1
US6677307B2 (en) * 1999-08-19 2004-01-13 Kaleidos Pharma, Inc. TGF-α polypeptides, functional fragments and methods of use therefor
TWI305778B (en) * 2001-12-03 2009-02-01 Nishida Teruo Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
JP4253743B2 (ja) * 2001-12-03 2009-04-15 輝夫 西田 新規ペプチドおよびその医薬用途
WO2007001016A1 (ja) * 2005-06-29 2007-01-04 National University Corporation Nagoya University 皮膚組織改善材及びその利用
KR20070111556A (ko) 2005-10-24 2007-11-22 (주)케어젠 섬유아세포 성장인자의 기능을 가지는 펩티드 및 이를이용한 화장품

Also Published As

Publication number Publication date
BRPI0911650B1 (pt) 2021-04-27
CN102027008A (zh) 2011-04-20
EP2275440B1 (en) 2016-12-21
CN102027008B (zh) 2013-07-31
EP2275440A4 (en) 2012-02-22
US20110160131A1 (en) 2011-06-30
KR101021197B1 (ko) 2011-03-11
US8501689B2 (en) 2013-08-06
KR20090108323A (ko) 2009-10-15
WO2009125925A2 (ko) 2009-10-15
BR122020010541B1 (pt) 2021-06-22
BRPI0911650B8 (pt) 2021-05-25
WO2009125925A3 (ko) 2009-12-17
JP5361988B2 (ja) 2013-12-04
ES2616658T3 (es) 2017-06-13
EP2275440A2 (en) 2011-01-19
JP2011519358A (ja) 2011-07-07
BR122020010515B1 (pt) 2021-04-27

Similar Documents

Publication Publication Date Title
BRPI0810172A2 (pt) Polipeptídeos de fator vii modificado e seus usos
HRP20190137T1 (hr) Stabilne formulacije polipeptida i njihova uporaba
DK3115370T3 (da) Biologisk aktive peptider
PL2252628T3 (pl) Koniugaty antagonistów peptydowych analogu bombezyny
IL218753A0 (en) Protein arrays and uses thereof
PL2942355T3 (pl) Nie-hemolityczne białka fuzyjne llo i ich zastosowanie
BRPI0914536A2 (pt) tiadiazoliloxifenilamidinas e o uso destas como fungicidas
BRPI0909908A2 (pt) implante de válvula cardíaca
BRPI1012321A2 (pt) anticorpos anti-vegf e seus usos
BRPI0919403A2 (pt) polipeptídeos modificados de eritropoetina animal e seus usos
EP2349097A4 (en) IMPROVED ARTIFICIAL HEARTLAP
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
EP2371333A4 (en) THIN CLEANER ARTICLE
BRPI1011384A2 (pt) pro-proteinas e seus metodos de uso
BRPI0921862A2 (pt) inibidores de raf e seus usos
BRPI0910746A2 (pt) reticuladores e seus usos
BRPI0812134A2 (pt) Anatagonistas de cxcr4 de peptídio cíclico
BRPI1012728A2 (pt) uso de tripeptídeos
BRPI0906387A2 (pt) Anticorpos alfa 5 - beta 1 e seus usos
BRPI0908853A2 (pt) composto oligopeptídicos e seus usos
BR112012002072A2 (pt) polipeptídeos de fator ix modificados e usos dos mesmos
PL2379085T3 (pl) Preparat farmaceutyczny zawierający supernatant z hodowli komórek jednojądrzastych
BRPI0812753A2 (pt) Combinações de substância ativas acaricidas
BR112013012129A2 (pt) composições de adesivos e seus usos
EP2251932A4 (en) ARTIFICIAL MEDIUM

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/03/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF